The development of tau pathology in sporadic AD is a progressive process [27], in which the soluble monomers of tau protein are hyperphosphorylated and pathologically aggregated to form PHF-tau, which, in turn, assembles to generate neurofibrillary tangles, leading to subsequent neuronal injury and cognitive decline [28]. The gene discussed is MAPT; the disease is Alzheimer disease.